This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
We review which stablecoins fall under regulatory scrutiny, the regimes that apply, and practical implications for users and providers alike.
19,598 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
SpaceX IPO plans could redefine the space economy, but Blue Origin is positioned to challenge. Learn how to evaluate ...
As the 2027 Social Security COLA outlook takes shape, retirees want clarity on budget impact. This guide breaks down ...
The Invesco PDBC ETF jumped higher as crude oil rallied to the 98th percentile of its five-year range, highlighting t...
Canoo has begun production of its electric vans, but internal documents show missing parts and late payments that cou...
Bank of America warns the Fed may be meaningfully deviating from most basic inflation-fighting rules, signaling a pot...
Analysts say the United States holds roughly $45 trillion in natural resources, a cushion that could delay debt press...
Tech-focused ETF VGT has rallied strongly, prompting analysts to weigh whether trump’s bull market could push another...
Ted Turner's open-loop model created the modern attention economy. This report analyzes its lasting impact on persona...
A bold NYC budget claim sparks debate about deficits and government finance. Learn how the idea of a zero-based, bala...
Today’s market moved in Ford’s favor as analysts primed optimism around Ford’s energy initiatives alongside its tradi...
The AI landscape is shifting from a few hardware champions to a broad ecosystem of software, cloud, and microchips. L...